Pat says,
<<It's not profitable for corporate American pharmaceutical companies to
develop a drug that could boost human milk supply.  Not just because of
the formula companies, but the lost in revenues to ALL pharmaceutical
companies who benefit from the illness and drugs used to treat those
illness caused by NOT breastfeeding.>>

I don't think I'd go so far as to say that.  Neither does my husband and
he's worked for Eli Lilly for 20 years.  I don't believe it's accurate
to say that no pharmaceutical company will ever bring a drug that has a
galactogogue effect to market because it would positively affect the
health of the general public thereby making their market share for
medicines shrink considerably.  I think if a company thought it would be
a major profit-maker to develop, patent and market such a drug, they
would.  They are all about the bottom line, but I don't think that
extends to the degree that they *want* people to be sick, so they will
need their product.  The only companies whose market stands to shrink
considerably if most babies are breastfed are formula companies.
Formula is a major money-maker for all of them, and for some, it is
about their only product!  I don't see a conspiracy here by the
pharmaceutical industry at large.  If anything, I think a company would
jump at making such a drug if they thought it would be a *blockbuster*
drug.  Their product line is diverse and we will never wipe out the need
for medications.

Marsha

             ***********************************************

To temporarily stop your subscription: set lactnet nomail
To start it again: set lactnet mail (or digest)
To unsubscribe: unsubscribe lactnet
All commands go to [log in to unmask]

The LACTNET mailing list is powered by L-Soft's renowned
LISTSERV(R) list management software together with L-Soft's LSMTP(R)
mailer for lightning fast mail delivery. For more information, go to:
http://www.lsoft.com/LISTSERV-powered.html